
Latus Biorevenue
Philadelphia, PennsylvaniaFounded 2022CEO Wayne Tupuola
Latus is a biotechnology company that develops innovative gene therapy candidates using precision delivery with the goal of improving the lives of patients, focusing on disorders of the central nervous system and peripheral diseases.
Latus Bio revenue
Latus Bio has not published its revenue. Growjo puts it at about $6.2M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $6.2MEST | Growjo estimate |
Latus Bio CEO & employees
Wayne Tupuola is CEO of Latus Bio. Latus Bio has 31 employees (September 2025, LinkedIn).
Latus Bio FAQ
What is Latus Bio's revenue?
Growjo estimates Latus Bio's revenue at about $6.2M a year (September 2025). The company hasn't published its own figure.
How many employees does Latus Bio have?
Latus Bio has 31 employees as of September 2025, according to LinkedIn.
Who is the CEO of Latus Bio?
Wayne Tupuola is the CEO of Latus Bio.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Latus Bio? Join the podcast